Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Dhakal B, Pagenkopf A, Mushtaq MU, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F.
Dhakal B, et al. Among authors: cunningham am.
Leuk Lymphoma. 2019 Oct;60(10):2558-2562. doi: 10.1080/10428194.2019.1585836. Epub 2019 Mar 8.
Leuk Lymphoma. 2019.
PMID: 30845856
Free PMC article.
No abstract available.